MX9800801A - Proteina mp52 arg humana. - Google Patents

Proteina mp52 arg humana.

Info

Publication number
MX9800801A
MX9800801A MX9800801A MX9800801A MX9800801A MX 9800801 A MX9800801 A MX 9800801A MX 9800801 A MX9800801 A MX 9800801A MX 9800801 A MX9800801 A MX 9800801A MX 9800801 A MX9800801 A MX 9800801A
Authority
MX
Mexico
Prior art keywords
human
bone
arg
treating
useful
Prior art date
Application number
MX9800801A
Other languages
English (en)
Inventor
Michio Kimura
Tomoaki Matsumoto
Mikiko Takahashi
Shinji Kawai
Yukio Fujino
Original Assignee
Bioph Biotech Entw Pharm Gmbh
Entwicklung Von Pharmaka Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioph Biotech Entw Pharm Gmbh, Entwicklung Von Pharmaka Mbh filed Critical Bioph Biotech Entw Pharm Gmbh
Publication of MX9800801A publication Critical patent/MX9800801A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invencion se relaciona con MP52 Arg humana y con una composicion médica farmacéutica, por ejemplo, para promover la morfogeneracion de cartílago y de hueso, que comprende MP52 Arg humana. En particular, la composicion médica esutil para tratar enfermedades oseas provocadas por metabolismo oseo anormal tal como osteoporosis, para el tratamiento de fracturas oseas con el proposito de reconstruccion ortopédica, trasplante de hueso, cirugía cosmética y terapéutica dental. Además, es util para el tratamiento de trastornos de cartílago.
MX9800801A 1995-08-03 1998-01-28 Proteina mp52 arg humana. MX9800801A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95112241 1995-08-03

Publications (1)

Publication Number Publication Date
MX9800801A true MX9800801A (es) 1998-11-29

Family

ID=8219499

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800801A MX9800801A (es) 1995-08-03 1998-01-28 Proteina mp52 arg humana.

Country Status (15)

Country Link
EP (1) EP0842274A1 (es)
JP (1) JP2000511155A (es)
KR (1) KR19990036081A (es)
CN (1) CN1192237A (es)
AR (1) AR003974A1 (es)
AU (1) AU699708B2 (es)
BR (1) BR9609983A (es)
CA (1) CA2227204A1 (es)
HU (1) HUP9900362A2 (es)
IL (1) IL122817A0 (es)
MX (1) MX9800801A (es)
NO (1) NO980375L (es)
PL (1) PL324822A1 (es)
WO (1) WO1997006254A1 (es)
ZA (1) ZA966489B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
GB9610281D0 (en) * 1996-05-16 1996-07-24 Ralston Stuart H Diagnostic method and apparatus
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
CA2806143A1 (en) 2010-07-30 2012-02-02 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mb H Drug delivery devices and growth factor formulations for accelerated wound healing
EP2537538A1 (en) 2011-06-22 2012-12-26 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH Bioresorbable Wound Dressing
EP2602264A1 (en) 2011-12-05 2013-06-12 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH GDF-5 mutant for inducing cartilage formation
KR101213355B1 (ko) * 2011-12-27 2012-12-18 오스템임플란트 주식회사 초기 안정성이 증진된 치과용 임플란트 및 그 제조 방법
JP2023507007A (ja) 2019-12-18 2023-02-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 疼痛及び軟骨破壊を治療するためのｇｄｆ－５変異体の使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ249113A (en) * 1992-02-12 1996-07-26 Bioph Biotech Entw Pharm Gmbh Recombinant dna encoding tgf-b, its production and pharmaceutical compositions thereof
IL110589A0 (en) * 1993-08-10 1994-11-11 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF- beta family
DE4420157B4 (de) * 1993-08-10 2013-04-25 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Neuer Wachstums/Differenzierungsfaktor der TGF-β-Familie
ATE319823T1 (de) * 1993-12-07 2006-03-15 Inst Genetics Llc Bmp-12, bmp-13 und diese enthaltende sehne- induzierende zusammensetzungen

Also Published As

Publication number Publication date
AR003974A1 (es) 1998-09-30
AU699708B2 (en) 1998-12-10
NO980375D0 (no) 1998-01-28
JP2000511155A (ja) 2000-08-29
AU6789196A (en) 1997-03-05
WO1997006254A1 (en) 1997-02-20
NO980375L (no) 1998-01-28
KR19990036081A (ko) 1999-05-25
EP0842274A1 (en) 1998-05-20
CN1192237A (zh) 1998-09-02
HUP9900362A2 (hu) 1999-05-28
IL122817A0 (en) 1998-08-16
CA2227204A1 (en) 1997-02-20
PL324822A1 (en) 1998-06-22
ZA966489B (en) 1997-02-26
BR9609983A (pt) 1999-01-12

Similar Documents

Publication Publication Date Title
EP0830138A4 (en) USE OF FIBROBLAST GROWTH FACTORS TO STIMULATE BONE GROWTH
ATE269102T1 (de) Verwendung von fibroblastwachstumsfaktoren zur stimulierung des knochenwachstums
DE69415810T2 (de) Netzförmiges, orthopädisches element welches den medullarkanal langer knochen ausfüllt
ATE288723T1 (de) Vorrichtung zur fixierung von osteoporotischen knochen
MXPA02006679A (es) Composicion farmaceutica.
EP0798001A3 (en) Collagen containing preparations for strengthening bone
ATE255367T1 (de) Marknagelsystem zur frakturheilung bzw. knochenverlängerung
EP0950417A3 (en) Treatment of skeletal disorders
MX9800801A (es) Proteina mp52 arg humana.
MXPA04003689A (es) Composiciones farmaceuticas y procedimientos para administrar agonistas selectivos del receptor ep2.
HUP0105312A2 (hu) Eljárások és gyógyszerkészítmények az ízületi porc gyógyítására és helyreállítására
AU5548801A (en) Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
HUP9802077A2 (hu) Alendronát alkalmazása csigolyatörések kockázatát csökkentő gyógyszerkészítmény előállítására
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
US5585117A (en) Use of a mixture of calcium hydroxide and oleum pedum tauri for collagen reformation in vivo
Verdoni et al. Chemical and physical influences in bone and cartilage regeneration: a review of literature
UA28497A (uk) Спосіб лікування нестабільних переломів дистального кінця променевої кістки
ATE468133T1 (de) Verwendung von g-csf als zusätzliche behandlung in die wiederherstellung von bindegewebe
TW224943B (en) The pharmaceutical composition for the stimulation of bone formation
MD1270F1 (en) Method for treatment of the hand navicular bone pseudarthrosis
Nounla et al. The external transfixation of the knee joint in a case of an open comminuted femoral fracture
UA28851A (uk) Спосіб оперативного лікування переломів дистального метаепіфізу великогомілкової кістки
YAGO et al. A case of mandibular retrusion treated with a hydroxyapatite and tricalcium phosphate composite implant
MD1268B2 (en) Method for surgical treatment of meta-physar fracture of children should bone distal part
RU95110152A (ru) Способ устранения деформации и укорочения бедра у детей и подростков, перенесших остеомиелит